NeuroNetworks Fund - aVenture Asset Manager Research
Location
New York City, NY, US
NeuroNetworks Fund focuses on investing in innovative treatments for neurodisorders, specifically targeting autism, epilepsy, and schizophrenia. The fund aims to bridge the gap between government funding and private capital in the neurodisease sector, accelerating the development of promising products that address unmet medical needs.
The fund's portfolio includes Stemina Biomarker Discovery, which has raised $3.1 million. NeuroNetworks Fund employs a unique model that combines philanthropic fundraising with venture capital investment, allowing them to support entrepreneurial companies developing new drugs and treatments. This approach helps promote self-sustainability in the neurodisorder treatment space.
NeuroNetworks Fund - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies2
Current Portfolio Count2
Top Investment Stages
Series A1 (100.0%)
Stage Mix
Series A 100%
Concentration shown as share of disclosed investments by stage.
